Association of clinical manifestations of secondary lymphedema and lymph node dissection sites in the lower extremities of patients with melanoma

References

• Swetter SM, Thompson JA, Albertini MR, et al. NCCN guidelines(R) insights: melanoma: cutaneous, version 2.2021. J Natl Compr Canc Netw. 2021;19(4):364–376. doi: 10.6004/jnccn.2021.0018.
   PubMed Web of Science ®Google Scholar
• Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics: update 2022. Eur J Cancer. 2022;170:236–255. doi: 10.1016/j.ejca.2022.03.008.
   PubMed Web of Science ®Google Scholar
• Wright FC, Souter LH, Kellett S, et al. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline. Curr Oncol. 2019;26(4):e541–e550. doi: 10.3747/co.26.4885.
   PubMed Web of Science ®Google Scholar
• Pinto M, Marotta N, Caraco C, et al. Quality of life predictors in patients with melanoma: a machine learning approach. Front Oncol. 2022;12:843611. doi: 10.3389/fonc.2022.843611.
   PubMed Web of Science ®Google Scholar
• Schadendorf D, van Akkooi ACJ, Berking C, et al. Melanoma. Lancet. 2018;392(10151):971–984. doi: 10.1016/S0140-6736(18)31559-9.
   PubMed Web of Science ®Google Scholar
• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–289. doi: 10.3322/caac.21349.
   PubMed Web of Science ®Google Scholar
• Bernas M, Thiadens SRJ, Stewart P, et al. Secondary lymphedema from cancer therapy. Clin Exp Metastasis. 2022;39(1):239–247. doi: 10.1007/s10585-021-10096-w.
   PubMed Web of Science ®Google Scholar
• Ren Y, Kebede MA, Ogunleye AA, et al. Burden of lymphedema in long-term breast cancer survivors by race and age. Cancer. 2022;128(23):4119–4128. doi: 10.1002/cncr.34489.
   PubMed Web of Science ®Google Scholar
• Roberson ML, Strassle PD, Fasehun LO, et al. Financial burden of lymphedema hospitalizations in the United States. JAMA Oncol. 2021;7(4):630–632. doi: 10.1001/jamaoncol.2020.7891.
   PubMed Web of Science ®Google Scholar
• Tada H, Teramukai S, Fukushima M, et al. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer. 2009;9:47. doi: 10.1186/1471-2407-9-47.
   PubMed Web of Science ®Google Scholar
• Biglia N, Zanfagnin V, Daniele A, et al. Lower body lymphedema in patients with gynecologic cancer. Anticancer Res. 2017;37(8):4005–4015.
   PubMed Web of Science ®Google Scholar
• Kim N, Kim H, Hwang JH, et al. Longitudinal impact of postmastectomy radiotherapy on arm lymphedema in patients with breast cancer: an analysis of serial changes in arm volume measured by infrared optoelectronic volumetry. Radiother Oncol. 2021;158:167–174. doi: 10.1016/j.radonc.2021.02.033.
   PubMed Web of Science ®Google Scholar
• Deban M, Vallance P, Jost E, et al. Higher rate of lymphedema with inguinal versus axillary complete lymph node dissection for melanoma: a potential target for immediate lymphatic reconstruction? Curr Oncol. 2022;29(8):5655–5663. doi: 10.3390/curroncol29080446.
   PubMed Web of Science ®Google Scholar
• Friedman JF, Sunkara B, Jehnsen JS, et al. Risk factors associated with lymphedema after lymph node dissection in melanoma patients. Am J Surg. 2015;210(6):1178–1184; discussion 1184. doi: 10.1016/j.amjsurg.2015.08.014.
   PubMed Web of Science ®Google Scholar
• Wrone DA, Tanabe KK, Cosimi AB, et al. Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases. Arch Dermatol. 2000;136(4):511–514. doi: 10.1001/archderm.136.4.511.
   PubMedGoogle Scholar
• Parker C, Castro E, Fizazi K, et al. Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(9):1119–1134. doi: 10.1016/j.annonc.2020.06.011.
   PubMed Web of Science ®Google Scholar
• Marth C, Landoni F, Mahner S, et al. Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv262. doi: 10.1093/annonc/mdy160.
   PubMed Web of Science ®Google Scholar
• Colombo N, Sessa C, Du Bois A, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Int J Gynecol Cancer. 2019;29(4):728–760. doi: 10.1136/ijgc-2019-000308.
   Web of Science ®Google Scholar
• Chuang LT, Temin S, Camacho R, et al. Management and care of women with invasive cervical cancer: American society of clinical oncology resource-stratified clinical practice guideline. J Glob Oncol. 2016;2(5):311–340. doi: 10.1200/JGO.2016.003954.
   PubMedGoogle Scholar
• Chen T, Lin Y, Tan Q. Risk factors for lower extremity lymphedema after inguinal lymphadenectomy in melanoma patients: a retrospective cohort study. Surg Open Sci. 2022;8:33–39. doi: 10.1016/j.sopen.2022.02.001.
   PubMedGoogle Scholar
• Gjorup CA, Dahlstroem K, Hendel HW, et al. Factors associated with melanoma-related limb lymphoedema. Acta Oncol. 2021;60(6):779–784. doi: 10.1080/0284186X.2021.1905175.
   PubMed Web of Science ®Google Scholar
• Kamijo E, Ishizuka K, Shikino K, et al. Physical findings and tests useful for differentiating lymphedema. J Gen Fam Med. 2021;22(4):227–228. doi: 10.1002/jgf2.425.
   PubMed Web of Science ®Google Scholar
• Tiwari A, Cheng KS, Button M, et al. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg. 2003;138(2):152–161. doi: 10.1001/archsurg.138.2.152.
   PubMedGoogle Scholar
• Armer JM, Hulett JM, Bernas M, et al. Best practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Cancer Rep. 2013;5(2):134–144. doi: 10.1007/s12609-013-0105-0.
   PubMedGoogle Scholar
• Campanholi LL, Baiocchi JMT, Batista BN, et al. Agreement between optoelectronic volumetry and circumferential girth measurements to diagnose lymphedema in patients submitted to axillary radical lymphadenectomy for treatment of cutaneous melanoma. Lymphat Res Biol. 2021;19(6):568–572. doi: 10.1089/lrb.2017.0081.
   PubMed Web of Science ®Google Scholar
• Spillane AJ, Saw RP, Tucker M, et al. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Ann Surg. 2008;248(2):286–293. doi: 10.1097/SLA.0b013e31817ed7c3.
   PubMed Web of Science ®Google Scholar
• Reza C, Norregaard S, Moffatt C, et al. Inter-observer and intra-observer variability in volume measurements of the lower extremity using perometer. Lymphat Res Biol. 2020;18(5):416–421. doi: 10.1089/lrb.2019.0063.
   PubMed Web of Science ®Google Scholar
• International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the international society of lymphology. Lymphology. 2013;46(1):1–11.
   PubMed Web of Science ®Google Scholar
• Kim YB, Hwang JH, Kim TW, et al. Would complex decongestive therapy reveal long term effect and lymphoscintigraphy predict the outcome of lower-limb lymphedema related to gynecologic cancer treatment? Gynecol Oncol. 2012;127(3):638–642. doi: 10.1016/j.ygyno.2012.09.015.
   PubMed Web of Science ®Google Scholar
• Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–2222. doi: 10.1056/NEJMoa1613210.
   PubMed Web of Science ®Google Scholar